Inventor · disambiguated record
Lillian Skidmore
Also filed as: SKIDMORE LILLIAN
11 granted patents·5 pending applications·46 citations·filing 2008–2022
88Inventor score
Top patents by PatentIndex Score
16 records- 0194US9975936B2Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2016·Granted May 22, 2018·12 cites·20 claims
- 0293US9517273B2Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2015·Granted Dec 13, 2016·15 cites·20 claims
- 0386US10961291B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2019·Granted Mar 30, 2021·1 cites·26 claims
- 0484US10954270B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2017·Granted Mar 23, 2021·2 cites·13 claims
- 0584US10377805B2Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their usesAMBRX INC·Filed 2018·Granted Aug 13, 2019·2 cites·21 claims
- 0684US9796754B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesMIAO ZHENWEI·Filed 2012·Granted Oct 24, 2017·8 cites·56 claims
- 0784US8946148B2Modified insulin polypeptides and their usesMIAO ZHENWEI·Filed 2008·Granted Feb 3, 2015·6 cites·3 claims
- 0877US11993637B2Modified FGF-21 polypeptides with non-naturally encoded amino acidsAMBRX INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 0975US2023348547A1Modified bovine g-csf polypeptides and their usesAMBRX INC·Filed 2022·Application pending·0 cites
- 1073US2022411469A1Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2022·Application pending·0 cites
- 1168US11420999B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2021·Granted Aug 23, 2022·0 cites·11 claims
- 1266US11542310B2Modified bovine G-CSF polypeptides and their usesAMBRX INC·Filed 2018·Granted Jan 3, 2023·0 cites·6 claims
- 1360US2021177980A1Pegylated porcine interferon and methods of use thereofELANCO US INC·Filed 2021·Application pending·0 cites
- 1452US10960080B2Pegylated porcine interferon and methods of use thereofELANCO US INC·Filed 2017·Granted Mar 30, 2021·0 cites·14 claims
- 1552US2015299288A1Modified Insulin Polypeptides and Their UsesAMBRX INC·Filed 2014·Application pending·0 cites
- 1644US2015080559A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin DerivativesAMBRX INC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →